CLONING AND SEQUENCING OF A NEW NONFUNCTIONAL CYP2D6 ALLELE - DELETION OF T-1795 IN EXON-3 GENERATES A PREMATURE STOP CODON

被引:60
作者
EVERT, B [1 ]
GRIESE, EU [1 ]
EICHELBAUM, M [1 ]
机构
[1] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,D-70376 STUTTGART,GERMANY
来源
PHARMACOGENETICS | 1994年 / 4卷 / 05期
关键词
D O I
10.1097/00008571-199410000-00005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:271 / 274
页数:4
相关论文
共 18 条
[1]  
BOCK KW, 1994, IN PRESS PHARMACOGEN
[2]   DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].
BROLY, F ;
GAEDIGK, A ;
HEIM, M ;
EICHELBAUM, M ;
MORIKE, K ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558
[3]   GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES [J].
DALY, AK ;
ARMSTRONG, M ;
MONKMAN, SC ;
IDLE, ME ;
IDLE, JR .
PHARMACOGENETICS, 1991, 1 (01) :33-41
[4]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186
[5]   GENETIC-BASIS FOR A LOWER PREVALENCE OF DEFICIENT CYP2D6 OXIDATIVE DRUG-METABOLISM PHENOTYPES IN BLACK-AMERICANS [J].
EVANS, WE ;
RELLING, MV ;
RAHMAN, A ;
MCLEOD, HL ;
SCOTT, EP ;
LIN, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2150-2154
[6]  
EVANS WE, 1991, PHARMACOGENETICS, V1, P143
[7]  
GAEDIGK A, 1991, AM J HUM GENET, V48, P943
[8]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[9]   PREDICTION OF PHENOTYPE FOR ACETYLATION AND FOR DEBRISOQUINE HYDROXYLATION BY DNA-TESTS IN HEALTHY-HUMAN VOLUNTEERS [J].
GRAF, T ;
BROLY, F ;
HOFFMANN, F ;
PROBST, M ;
MEYER, UA ;
HOWALD, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) :399-403
[10]  
HANIOKA N, 1990, AM J HUM GENET, V47, P994